Pharma companies in Europe push for US-level drug prices [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
Amid the threat of tariffs, pharmaceutical investments in the US are said to have surged since President Donald Trump's return to power. In a letter published in the Financial Times , Novartis CEO Vas Narasimhan and Sanofi CEO Paul Hudson have proposed that the European Commission set a target to spend on medicines and vaccines. According to estimates from the US Government, the country spends almost triple the amount on both generic and branded drugs compared to other similar nations. The chief executives said that the biopharma sector in the EU is being held back by artificially low drug prices, which they say discourage innovation. They point to data showing that two years after approval in the US, 30% of those same medicines are still unavailable in Europe. The executives emphasise that without urgent action, Europe may face a decline and an acceleration in the departure of companies. The Trump administration has aimed to address the high prices of drugs in the countr
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA [Yahoo! Finance]Yahoo! Finance
- Sanofi Agrees to Buy Dynavax for $2.2 Billion After FDA MS Drug Rejection [Yahoo! Finance]Yahoo! Finance
- Delayed MS Decision and Trial Miss Add to Sanofi's R&D Challenges [Yahoo! Finance]Yahoo! Finance
- Honoring 45 Organ, Eye and Tissue Donors, Living Donors and Recipients: The 2026 OneLegacy Donate Life Rose Parade® Float Celebrates 23 Years of Participation in the Iconic Rose Parade® [Yahoo! Finance]Yahoo! Finance
- Sanofi to Buy Dynavax to Boost Vaccines Business [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 12/29/25 - Form 6-K
- 12/29/25 - Form 6-K
- 12/23/25 - Form 6-K
- SNY's page on the SEC website